Annual EBITDA
-$6.16 M
-$180.30 K-3.02%
April 1, 2024
Summary
- As of February 7, 2025, HSCS annual EBITDA is -$6.16 million, with the most recent change of -$180.30 thousand (-3.02%) on April 1, 2024.
- During the last 3 years, HSCS annual EBITDA has fallen by -$3.87 million (-169.28%).
- HSCS annual EBITDA is now -169.28% below its all-time high of -$2.29 million, reached on April 30, 2021.
Performance
HSCS EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBITDA
-$1.93 M
+$64.90 K+3.25%
October 1, 2024
Summary
- As of February 7, 2025, HSCS quarterly EBITDA is -$1.93 million, with the most recent change of +$64.90 thousand (+3.25%) on October 1, 2024.
- Over the past year, HSCS quarterly EBITDA has dropped by -$375.50 thousand (-24.14%).
- HSCS quarterly EBITDA is now -362.71% below its all-time high of -$417.30 thousand, reached on July 31, 2021.
Performance
HSCS Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBITDA
-$7.20 M
-$375.50 K-5.50%
October 1, 2024
Summary
- As of February 7, 2025, HSCS TTM EBITDA is -$7.20 million, with the most recent change of -$375.50 thousand (-5.50%) on October 1, 2024.
- Over the past year, HSCS TTM EBITDA has dropped by -$1.56 million (-27.57%).
- HSCS TTM EBITDA is now -822.96% below its all-time high of -$780.20 thousand, reached on April 30, 2021.
Performance
HSCS TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
HSCS EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -3.0% | -24.1% | -27.6% |
| 3 y3 years | -169.3% | -24.1% | -27.6% |
| 5 y5 years | -64.4% | -24.1% | -27.6% |
HSCS EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -169.3% | at low | -76.7% | +3.3% | -122.2% | at low |
| 5 y | 5-year | -169.3% | at low | -362.7% | +3.3% | -823.0% | at low |
| alltime | all time | -169.3% | at low | -362.7% | +3.3% | -823.0% | at low |
Heart Test Laboratories EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Oct 2024 | - | -$1.93 M(-3.3%) | -$7.20 M(+5.5%) |
| Jul 2024 | - | -$2.00 M(+14.1%) | -$6.83 M(+11.3%) |
| Apr 2024 | -$6.16 M(+3.0%) | -$1.75 M(+14.6%) | -$6.13 M(+4.5%) |
| Jan 2024 | - | -$1.53 M(-1.9%) | -$5.87 M(+4.0%) |
| Oct 2023 | - | -$1.56 M(+19.3%) | -$5.64 M(-3.6%) |
| Jul 2023 | - | -$1.30 M(-12.1%) | -$5.86 M(-2.0%) |
| Apr 2023 | -$5.98 M | -$1.48 M(+13.9%) | -$5.98 M(-7.5%) |
| Jan 2023 | - | -$1.30 M(-26.3%) | -$6.46 M(+3.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Oct 2022 | - | -$1.77 M(+24.1%) | -$6.25 M(+15.0%) |
| Jul 2022 | - | -$1.42 M(-27.7%) | -$5.44 M(+22.7%) |
| Apr 2022 | -$4.43 M(+93.8%) | -$1.97 M(+80.2%) | -$4.43 M(+36.7%) |
| Jan 2022 | - | -$1.09 M(+15.0%) | -$3.24 M(+50.9%) |
| Oct 2021 | - | -$950.30 K(+127.7%) | -$2.15 M(+79.4%) |
| Jul 2021 | - | -$417.30 K(-46.5%) | -$1.20 M(+53.5%) |
| Apr 2021 | -$2.29 M(-38.9%) | -$780.20 K | -$780.20 K |
| Apr 2020 | -$3.74 M | - | - |
FAQ
- What is Heart Test Laboratories annual EBITDA?
- What is the all time high annual EBITDA for Heart Test Laboratories?
- What is Heart Test Laboratories annual EBITDA year-on-year change?
- What is Heart Test Laboratories quarterly EBITDA?
- What is the all time high quarterly EBITDA for Heart Test Laboratories?
- What is Heart Test Laboratories quarterly EBITDA year-on-year change?
- What is Heart Test Laboratories TTM EBITDA?
- What is the all time high TTM EBITDA for Heart Test Laboratories?
- What is Heart Test Laboratories TTM EBITDA year-on-year change?
What is Heart Test Laboratories annual EBITDA?
The current annual EBITDA of HSCS is -$6.16 M
What is the all time high annual EBITDA for Heart Test Laboratories?
Heart Test Laboratories all-time high annual EBITDA is -$2.29 M
What is Heart Test Laboratories annual EBITDA year-on-year change?
Over the past year, HSCS annual EBITDA has changed by -$180.30 K (-3.02%)
What is Heart Test Laboratories quarterly EBITDA?
The current quarterly EBITDA of HSCS is -$1.93 M
What is the all time high quarterly EBITDA for Heart Test Laboratories?
Heart Test Laboratories all-time high quarterly EBITDA is -$417.30 K
What is Heart Test Laboratories quarterly EBITDA year-on-year change?
Over the past year, HSCS quarterly EBITDA has changed by -$375.50 K (-24.14%)
What is Heart Test Laboratories TTM EBITDA?
The current TTM EBITDA of HSCS is -$7.20 M
What is the all time high TTM EBITDA for Heart Test Laboratories?
Heart Test Laboratories all-time high TTM EBITDA is -$780.20 K
What is Heart Test Laboratories TTM EBITDA year-on-year change?
Over the past year, HSCS TTM EBITDA has changed by -$1.56 M (-27.57%)